Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence

✍ Scribed by Zhao, Juping; Zhu, Yu; Zhang, Chongyu; Wang, Xiaojing; He, Hongchao; Wang, Haofei; Wu, Yuxuan; Zhou, Wenlong; Shen, Zhoujun

• Book ID: 123017555
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 160 KB
• Volume: 31
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2012.04.019